Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Novartis Investigative Site, Westmead

Novartis Investigative Site, Woolloongabba

Novartis Investigative Site, Taipei

Novartis Investigative Site, Gyeonggi-do

Novartis Investigative Site, Granada

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Oldenburg

Novartis Investigative Site, Madrid

Novartis Investigative Site, Hanover

Novartis Investigative Site, Oviedo

Novartis Investigative Site, Göttingen

Sarah Cannon Research Institute Dept of Onc, Nashville

Novartis Investigative Site, La Tronche

Novartis Investigative Site, Reggio Emilia

Novartis Investigative Site, Essen

Novartis Investigative Site, Meldola

Karmanos Cancer Institute Wayne St Karmanos, Detroit

Novartis Investigative Site, Zaragoza

Novartis Investigative Site, Lille Cédex

Novartis Investigative Site, Ancona

Novartis Investigative Site, Frankfurt

University of Chicago SC, Chicago

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Tainan City

Highlands Oncology Group, Fayetteville

Novartis Investigative Site, Freiburg im Breisgau

Novartis Investigative Site, Songkhla

Novartis Investigative Site, Singapore

Novartis Investigative Site, Haifa

Novartis Investigative Site, Kfar Saba

Novartis Investigative Site, Ramat Gan

Novartis Investigative Site, Tel Aviv

University of Texas/MD Anderson Cancer Center Dept of Onc, Houston

Novartis Investigative Site, Ottawa

Novartis Investigative Site, Toronto

Novartis Investigative Site, Shatin, New Territories

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Utrecht

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Oslo

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona